Raymond D Stapleton Jr insider trades: Genocea Biosciences (GNCA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Raymond reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 25, 2022 | GNCA | ↓ Sell | 2,500 | $0.09 | $223 | Direct | May 26, 2022 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Raymond D Stapleton Jr's insider trades
Raymond D Stapleton Jr is Chief Technology Officer at Genocea Biosciences (GNCA). Since May 25, 2022, Raymond has reported no open-market purchases and 1 sale worth $223 on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GNCA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.